Interstitial Lung Disease

doi:10.1007/978-3-319-63895-9_40

Paper

Interstitial Lung Disease

Published 2019 · Christopher J. Rees, Charles V. Pollack, Victoria G. Riese

Differential Diagnosis of Cardiopulmonary Disease

96

Citations

2

Influential Citations

Full text Semantic Scholar

Abstract

This book provides a basic pathobiology and a complete description of individual disease entities. The book covers a wide array of disorders sarcoidosis, asbestosis, hypersensitivity pneumonitis, drug induced lung disease, connective tissue disease, and pulmonary vasculitis to name but a few. This new edition also features an examination of future potential therapies for interstitial lung disease. Interstitial Lung Disease is divided into three sections. The Clinical Approach section provides the basis for recognizing the key features that allow a specific diagnosis to be achieved. The section dedicated to Basic Mechanisms emphasizes the many advances in genetics and cellular and molecular biology that have greatly expanded our understanding of the biological processes involved in the pathogenesis of the interstitial lung diseases. The third section titled Clinical Entities describes the clinical manifestations, radiologic patterns, histopathological features, and management of the specific process.

Study Snapshot

Key takeawayInterstitial lung diseases, including sarcoidosis, asbestosis, hypersensitivity pneumonitis, drug-induced lung disease, connective tissue disease, and pulmonary vasculitis, are characterized by diverse clinical manifestations, radiologic patterns, histopathological features, and management strategies.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Interstitial Lung Disease

References

Citations